BridgeBio
Palo Alto · Founded 2015
About BridgeBio
BridgeBio is a biotechnology company that focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D. BridgeBio creates a bridge from advancements in genetic science to patients with unmet needs via the entrepreneurial engine required to make life-changing medicines as rapidly as possible. BridgeBio's mission is to discover, create, test, and deliver transformative medicines to treat patients with genetic diseases.
Company Facts
- Founded: 2015
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 501 – 1,000
- Estimated revenue: $100K – $500K
- Total funding: $4.9B
- Funding stage: IPO
- Last round: Post-IPO Debt (Jan 2026)
- Ticker: nasdaq:BBIO
- Website: bridgebio.com
- Phone: 650-391-9740
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/bridgebio-55642 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.